Inventors:
Mahboob Rahman - Sharon MA, US
Dennis Poe - Chestnut Hill MA, US
Hyon Choi - Lexington MA, US
International Classification:
A61K031/42
Abstract:
Disclosed herein are methods for treating immune-mediated ear disorders, such as IMCVDs, or their symptoms, involving administration of a therapeutically-effective amount of a TNF antagonist, such as etanercept or infliximab, or a therapeutically-effective amount of a pyrimidine synthesis inhibitor, such as leflunomide.